HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-06-14Clinical Trial Update: Impact of HIV Drug Resistance Testing, and Subsequent Change to an Individualized Therapy in Tanzania [NA]
Clinical Trial Update reports on the impact of HIV drug resistance testing and subsequent changes to individualized therapy in Tanzania. The…
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: ARV Concentrations in Hair
A University of North Carolina–led HIV trial (NCT02768779) evaluating antiretroviral concentrations in hair has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas [Phase 1, Phase 2]
Clinical trial evaluating vorinostat in combination with chemotherapy and rituximab for HIV-related and other aggressive B-cell lymphomas; t…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC [Phase 3]
Phase 3 switch study evaluating switching to emtricitabine/tenofovir alafenamide in HIV-1-infected adults virologically suppressed on ABC/3T…
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Group Clinical Visit Adherence Intervention for HIV+ Women of Color [NA]
A clinical trial evaluating a group clinical visit adherence intervention for HIV-positive women of color has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults [Phase 3]
A Phase 3 trial evaluating switching virologically suppressed HIV-1 patients from boosted protease inhibitor regimens to Bictegravir/Emtrici…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults [Phase 3]
Phase 3 trial evaluating bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir/emtricitabine/tenofovir alafenamide in antiretr…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Raltegravir in the Swiss HIV Cohort Study
The clinical trial evaluating raltegravir in the Swiss HIV Cohort Study has completed.
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: Diagnostic of Human Immunodeficiency Virus (HIV) and Other Sexual Transmission Diseases (STD) in High Risk Populations: Men Who Have Sex With Men (MSM) Users of Chemsex
An ongoing clinical trial evaluating diagnostic approaches for HIV and other sexually transmitted infections in high-risk men who have sex w…
-
FDA approval · 2018-06-04FDA Approved: PREZCOBIX — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for Prezcobix (darunavir ethanolate and cobicistat) from Janssen Products, LP.
-
CLINICAL_TRIALS research · 2018-06-04Clinical Trial Update: Abnormal Glucose Metabolism in HIV-infected Patients [NA]
A Mahidol University-sponsored clinical trial update notes abnormal glucose metabolism in HIV-infected patients, with the trial status liste…
-
FDA approval · 2018-05-30FDA Approved: TROGARZO — Supplemental Application (Theratechnologies Inc.)
FDA approved a supplemental application for TROGARZO (ibalizumab) submitted by Theratechnologies Inc., related to regulatory status for HIV-…
-
CLINICAL_TRIALS withdrawal · 2018-05-30Clinical Trial Update: Impact of Screening Patients With HIV for Kidney Disease
The clinical trial evaluating screening HIV patients for kidney disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Allogeneic Transplant in HIV Patients (BMT CTN 0903) [Phase 2]
Phase 2 clinical trial evaluating allogeneic transplant in HIV-positive patients with leukemia or lymphoma; completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel [Phase 1]
This update outlines the pharmacokinetic and safety findings from a Phase 1 study of vaginal rings containing dapivirine and levonorgestrel …
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: SEPA III: The Effectiveness Trial [NA]
SEPA III: The Effectiveness Trial, sponsored by the University of Miami, has completed according to the clinical trial update and concerns H…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate [NA]
A completed clinical trial evaluating an antioxidant from microencapsulated red pomegranate in HIV-positive patients.
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy Volunteers [Phase 1]
This Phase 1 study evaluates the pharmacokinetics of dolutegravir and darunavir/cobicistat when given together in healthy volunteers. Result…
-
CLINICAL_TRIALS research · 2018-05-22Clinical Trial Update: Targeted Clinical Strategies and Low Level Viraemia (LLV) in Boosted Protease Inhibitor Therapy
This clinical trial update discusses approaches to address low-level viraemia in patients on boosted protease inhibitor therapy for HIV.
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons [Phase 2]
Phase 2 trial update on the efficacy and safety of a GSK HIV vaccine in ART-naïve HIV-1 infected persons; results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy [NA]
The Quatro Study, an acceptability study of placebo vaginal delivery forms for HIV prevention and contraception, has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Eplerenone in HIV Associated Abdominal Fat Accumulation [NA]
A clinical trial evaluating eplerenone for HIV-associated abdominal fat accumulation has completed, and the study results were posted on 201…
-
FDA approval · 2018-05-15FDA Approved: RETACRIT — Original Application (Vifor (International) Inc.)
The FDA approved Retacrit (epoetin alfa-epbx) under Original Application BLA125545, establishing it as a biosimilar to epoetin alfa. The app…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD) [Phase 1]
This Phase 1 pharmacokinetics and safety study evaluated fostemsavir (BMS-663068) in subjects with normal renal function and varying degrees…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics [NA]
Clinical trial assessing a brief intervention to reduce non-injecting drug use among HIV primary care patients; study completed with results…